91 related articles for article (PubMed ID: 33015156)
1. miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer.
Liu M; Wang W; Chen H; Lu Y; Yuan D; Deng Y; Ran D
Biomed Res Int; 2020; 2020():2474235. PubMed ID: 33015156
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis.
Chen Y; Sun L; Li L
J Obstet Gynaecol; 2024 Dec; 44(1):2311658. PubMed ID: 38348790
[TBL] [Abstract][Full Text] [Related]
3. Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions.
Yi B; Xu Q; Zhang Z; Zhang J; Xu Y; Huang L; Hu Y; Tu Q; Chen J
Front Oncol; 2022; 12():812076. PubMed ID: 35692793
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Cervicovaginal Microecological Changes and HPV16/18 Infection and Cervical Cancer in Women of Childbearing Age.
Zhang Z; Yang Y; Zhang L; Wu Y; Jia P; Ma Q; Wang D
Ann Clin Lab Sci; 2023 Nov; 53(6):825-834. PubMed ID: 38182150
[TBL] [Abstract][Full Text] [Related]
5. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract][Full Text] [Related]
6. Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer.
Aftab M; Poojary SS; Seshan V; Kumar S; Agarwal P; Tandon S; Zutshi V; Das BC
Sci Rep; 2021 May; 11(1):10323. PubMed ID: 33990639
[TBL] [Abstract][Full Text] [Related]
7. Laurencia johnstonii extract reverses early lesions in the K14E7HPV16 murine cervical carcinogenesis model.
Arvizu-Hernandez E; Hernandez-Guerrero CJ; Alvarez-Rios E; Gariglio P; Cornejo-Garrido J; Ocadiz-Delgado R
J Med Virol; 2024 Apr; 96(4):e29571. PubMed ID: 38563330
[TBL] [Abstract][Full Text] [Related]
8. MiR-150 and miR-155 expression predicts survival of cervical cancer patients: a translational approach to novel prognostic biomarkers.
Santos JMO; Tavares V; Gil da Costa RM; Medeiros R
Biomarkers; 2023 Dec; 28(7):617-627. PubMed ID: 37942654
[TBL] [Abstract][Full Text] [Related]
9. Effect of Productive Human Papillomavirus 16 Infection on Global Gene Expression in Cervical Epithelium.
Kang SD; Chatterjee S; Alam S; Salzberg AC; Milici J; van der Burg SH; Meyers C
J Virol; 2018 Oct; 92(20):. PubMed ID: 30045992
[TBL] [Abstract][Full Text] [Related]
10. An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer.
Zou J; Li Y; Chen T; Zhu C
Transl Cancer Res; 2024 Apr; 13(4):1876-1886. PubMed ID: 38737678
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
Wang X; Tang S; Le SY; Lu R; Rader JS; Meyers C; Zheng ZM
PLoS One; 2008 Jul; 3(7):e2557. PubMed ID: 18596939
[TBL] [Abstract][Full Text] [Related]
12. The E6 and E7 proteins of beta3 human papillomavirus 49 can deregulate both cellular and extracellular vesicles-carried microRNAs.
Chiantore MV; Iuliano M; Mongiovì RM; Dutta S; Tommasino M; Di Bonito P; Accardi L; Mangino G; Romeo G
Infect Agent Cancer; 2022 Jun; 17(1):29. PubMed ID: 35705991
[TBL] [Abstract][Full Text] [Related]
13. HPV16-miRNAs exert oncogenic effects through enhancers in human cervical cancer.
Wang Y; Wang X; Liu Y; He Y; Duan X; Li Q; Huang Y; Xu G; Lu Q
Cancer Cell Int; 2024 May; 24(1):172. PubMed ID: 38750489
[TBL] [Abstract][Full Text] [Related]
14. Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms.
Jarych D; Mikulski D; Wilczyński M; Wilczyński JR; Kania KD; Haręża D; Malinowski A; Perdas E; Nowak M; Paradowska E
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255835
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Profiling of MicroRNAs in HPV-Induced Warts and Normal Skin.
Al-Eitan LN; Alghamdi MA; Tarkhan AH; Al-Qarqaz FA
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766385
[No Abstract] [Full Text] [Related]
16. Screening for High-Risk Human Papillomavirus Reveals HPV52 and HPV58 among Pediatric and Adult Patient Saliva Samples.
Hinton H; Herrera L; Valenzuela S; Howard KM; Kingsley K
Dent J (Basel); 2024 Feb; 12(3):. PubMed ID: 38534280
[TBL] [Abstract][Full Text] [Related]
17. Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer.
Wang Y; Yang J; Wang Y
J Ultrasound Med; 2024 Apr; 43(4):791-798. PubMed ID: 38269478
[TBL] [Abstract][Full Text] [Related]
18. Interferon epsilon mRNA expression could represent a potential molecular marker in cervical cancer.
Marrero-Rodríguez D; Baeza-Xochihua V; Taniguchi-Ponciano K; Huerta-Padilla V; Ponce-Navarrete G; Mantilla A; Hernandez D; Hernandez A; Gomez-Gutierrez G; Serna-Reyna L; Figueroa-Corona MDP; Gomez-Virgilio L; Rodriguez-Esquivel M; Romero-Morelos P; Vazquez-Moreno MA; Loza-Medrano S; Ortiz-Leon J; Hernandez-Rico E; Meraz-Rios M; Salcedo M
Int J Clin Exp Pathol; 2018; 11(4):1979-1988. PubMed ID: 31938304
[TBL] [Abstract][Full Text] [Related]
19. Risk of HPV-related extra-cervical cancers in women treated for cervical intraepithelial neoplasia.
Preti M; Rosso S; Micheletti L; Libero C; Sobrato I; Giordano L; Busso P; Gallio N; Cosma S; Bevilacqua F; Benedetto C
BMC Cancer; 2020 Oct; 20(1):972. PubMed ID: 33028248
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis uncovers the diagnostic value of miR-192-5p/HNF1A-AS1/VIL1 panel in cervical adenocarcinoma.
Xu J; Zou J; Wu L; Lu W
Sci Rep; 2020 Oct; 10(1):16584. PubMed ID: 33024199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
